DreamCIS – Startup Investor Profile

DreamCIS provides CRO and one of the largest CROs.

Location: Seoul

Country:

Investment Regions:

Investment Stages: pre-seed, seed

Website: http://www.dreamcis.com/

AI Reasoning: Found evidence DreamCIS made a strategic investment (15억 KRW) in G2G Bio (지투지바이오) on 2022-11-21. Also multiple sources show activity 2024-2025 about corporate actions (IR 2025, press releases). The most recent identified direct investment is November 21, 2022, which is 36+ months before the evaluation date, but additional sources indicate investments/transactions reported in 2024 (e.g., Medipana reports investments in subsidiary Meditip in Nov 2024) indicating DreamCIS engaged in investment-related activity within last 12 months; specifically Meditip funding reported Nov 14, 2024, which is 12 months and some days before the evaluation date, placing the latest known investment around 11 months prior – within 12 to 6 months window? However, counting from Nov 14, 2024 to current yields about 11.5 months, which corresponds to ‘low-active’. But presence of 2025 references (June 2025 IR) shows corporate activity but not direct new investments. The clearest recent investment-related report is Nov 14, 2024 (Meditip) – 11.5 months ago, so tag should be ‘low-active’. Yet earlier I incorrectly set ‘active’. After re-evaluation, latest confirmed investment is Nov 14, 2024 in Meditip; that falls between 12 and 6 months ago, therefore classification: low-active.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.